BCAP31 and neurodegenerative disease: Recently, our team has further expanded this understanding; we found that BAP31 can regulate superoxide levels in microglia by modulating the p22phox and Keap1/Nrf2/HO-1 signaling pathways, thereby participating in the pathological regulation of neurodegenerative diseases [24].